Challenge study shows efficacy of RSV vaccine in healthy adults
Silence for thought: Special interneuron networks in the human brain
23 June 2022Standard definition set released for diagnosis and treatment of COVID-19 complications
23 June 2022Challenge study shows efficacy of RSV vaccine in healthy adults
For healthy adults, the bivalent prefusion F respiratory syncytial virus (RSVpreF) vaccine is effective against symptomatic RSV infection and viral shedding, according to a study published in the June 23 issue of the New England Journal of Medicine.
